Neoadjuvant Propanolol in Breast Cancer

Summary

This trial is a Phase II study using the "window-of-opportunity" design in which the treatment-free window between breast cancer diagnosis and surgical tumor resection is used to study the biological effects of the beta blocker propranolol .

Timeline

Start

2015-09-01

Primary completion

2017-05-01

Completion

2017-05-01

Outcome

Outcome not reported

Stopped (Enrollment): “poor accrual”

Drugs

Indications